APO-SALVENT AEM 100MCG 100 MCG — DIN 00790419
SALBUTAMOL : 100 MCG · APOTEX INC · METERED-DOSE AEROSOL · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is APO-SALVENT AEM 100MCG?
APO-SALVENT AEM 100MCG 100 MCG contains SALBUTAMOL : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 00790419, held by APOTEX INC, supplied as METERED-DOSE AEROSOL for INHALATION administration. Health Canada currently lists it as cancelled post market, status dated 17-Apr-2025. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Salbutamol cost around the world?
Salbutamol is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 39 | 42 | SAR███.██ |
| Morocco | PPV (public price) | 13 | 34 | MAD███.██ |
| South Africa | single exit price | 25 | 31 | ZAR███.██ |
| Australia | ex-manufacturer | 8 | 17 | AUD███.██ |
| Czechia | max producer price (ex-factory) | 4 | 9 | CZK███.██ |
| Romania | max producer price | 6 | 6 | RON███.██ |
| Austria | KVP (Kassenverkaufspreis) | 5 | 5 | EUR███.██ |
| Greece | producer price (ex-factory) | 5 | 5 | EUR███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| Bahrain | retail (max) | 2 | 2 | BHD███.██ |
| Spain | PVP con IVA (public price) | 2 | 2 | EUR███.██ |
| Sweden | AIP (pharmacy purchase price) | 2 | 2 | SEK███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
| Slovakia | categorised final price | 1 | 1 | EUR███.██ |
165 pack listings across 121 brand entries and 16 price bases, refreshed 08 Sep 2026. Ranges span every Salbutamol pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Salbutamol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
20 holders have a Canadian DIN containing Salbutamol, across 63 DINs, of which 11 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| GLAXOSMITHKLINE INC | 11 | 3 | VENTODISK 200MCG, VENTODISK 400MCG, VENTOLIN DISKUS, VENTOLIN HFA, VENTOLIN INHALER, +5 more | Sourceable in Canada |
| TEVA CANADA LIMITED | 8 | 3 | BACA RESPICLICK, RATIO-SALBUTAMOL, TEVA-SALBUTAMOL HFA, TEVA-SALBUTAMOL STERINEBS P.F. | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 3 | PMS-SALBUTAMOL | Sourceable in Canada |
| APOTEX INC | 6 | 1 | APO-SALBUTAMOL HFA, APO-SALVENT 5MG/ML, APO-SALVENT AEM 100MCG, APO-SALVENT STERULES | Sourceable in Canada |
| SANIS HEALTH INC | 1 | 1 | SALBUTAMOL HFA | Sourceable in Canada |
| GLAXO CANADA INC | 9 | 0 | VENTODISK PWR 200MCG/BLISTER, VENTODISK PWR 400MCG/BLISTER, VENTOLIN INHALER 100MCG/AEM, VENTOLIN NEBULES P.F. LIQ INH 1.25MG/2.5ML, VENTOLIN NEBULES P.F. SOL 2.5MG/2.5ML, +4 more | No marketed DIN |
| PHARMEL INC | 4 | 0 | PHL-SALBUTAMOL RESPIRATOR SOLUTION | No marketed DIN |
| ASTRAZENECA CANADA INC | 3 | 0 | SALBUTAMOL NEBUAMP 0.05%, SALBUTAMOL NEBUAMP 0.1%, SALBUTAMOL NEBUAMP 0.2% | No marketed DIN |
| BAKER CUMMINS INC | 2 | 0 | BCI SALBUTAMOL INHALATION SOLUTION | No marketed DIN |
| IVAX PHARMACEUTICALS INCORPORATED | 2 | 0 | SALBUTAMOL INHALATION SOLUTION | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-SALBUTAMOL PLASTIC AMPULES 1 MG/ML, NU-SALBUTAMOL PLASTIC AMPULES 2 MG/ML | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 2 | 0 | RATIO-SALBUTAMOL, RATIO-SALBUTAMOL HFA | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MCG |
|---|---|
| Dosage form | METERED-DOSE AEROSOL |
| Route | INHALATION |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Salbutamol |
|---|---|
| ATC code | R03AC02 |
| AHFS class | 72:00.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00790419 |
|---|---|
| DIN (unpadded, as printed on some documents) | 790419 |
| Brand name | APO-SALVENT AEM 100MCG |
| Generic / active ingredient | SALBUTAMOL : 100 MCG |
| Market authorization holder | APOTEX INC |
| Health Canada schedule | Prescription |
| ATC code | R03AC02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03AC |
| Current status | CANCELLED POST MARKET |
| Status date | 17-Apr-2025 |
| Original market date | 1988-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Salbutamol in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
11 of 63 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | APOTEX INC | MARKETED | 02245669 |
| PMS-SALBUTAMOL | 0.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | 02208245 |
| PMS-SALBUTAMOL | 1 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | 02208229 |
| PMS-SALBUTAMOL | 2 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | 02208237 |
| SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | SANIS HEALTH INC | MARKETED | 02419858 |
| TEVA-SALBUTAMOL HFA | 100 MCG | METERED-DOSE AEROSOL | TEVA CANADA LIMITED | MARKETED | 02326450 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | 02173360 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | 01926934 |
| VENTOLIN DISKUS | 200 MCG | POWDER | GLAXOSMITHKLINE INC | MARKETED | 02243115 |
| VENTOLIN HFA | 100 MCG | METERED-DOSE AEROSOL | GLAXOSMITHKLINE INC | MARKETED | 02241497 |
2 · Same class — other molecules in ATC R03AC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Salbutamol | AIROMIR · APO-SALBUTAMOL HFA · APO-SALVENT 5MG/ML · APO-SALVENT AEM 100MCG · +43 more | 63 | 11 | Yes |
| Formoterol | FORADIL DRY POWDER CAPSULES FOR INHALATION · OXEZE TURBUHALER | 3 | 2 | Yes |
| Salmeterol | SEREVENT (25MCG/ACTUATION) · SEREVENT DISKHALER DISK (50MCG/DOSE) · SEREVENT DISKUS (50MCG/DOSE) · SEREVENT- AEM 25MCG/AEM · +1 more | 5 | 1 | Yes |
| Terbutaline | BRICANYL TURBUHALER | 1 | 1 | Yes |
| Fenoterol | BEROTEC 1MG/ML · BEROTEC AEM 100MCG/DOSE · BEROTEC FORTE METERED AER · BEROTEC UDV INHALATION SOLUTION 0.25MG/ML · +1 more | 5 | 0 | Not in Canada |
| Procaterol | PRO-AIR AEROSOL 10MCG/AEM | 1 | 0 | Not in Canada |
| Pirbuterol | MAXAIR AEM 240MCG/AEM | 1 | 0 | Not in Canada |
| Olodaterol | STRIVERDI RESPIMAT | 1 | 0 | Not in Canada |
| Indacaterol | ONBREZ BREEZHALER | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R03AK | Formoterol And Budesonide · Formoterol And Mometasone · Indacaterol And Mometasone · Salbutamol And Sodium Cromoglicate · Salmeterol And Fluticasone · +1 more | 26 | 20 |
| R03AL | Fenoterol And Ipratropium Bromide · Formoterol And Aclidinium Bromide · Formoterol And Glycopyrronium Bromide · Formoterol, Glycopyrronium Bromide And Beclometasone · Formoterol, Glycopyrronium Bromide And Budesonide · +6 more | 18 | 11 |
| R03AA | Epinephrine | 4 | 0 |
| R03AB | Isoprenaline · Orciprenaline | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is APO-SALVENT AEM 100MCG called?
The same molecule, Salbutamol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| DILATOR | Latin | Morocco |
| Ventolin | Latin | Australia, Czechia, Saudi Arabia, Slovakia |
| VENTOLINE | Latin | Morocco |
| BUTAMYL | Latin | Morocco |
| BUVENTOL EASYHALER | Latin | Czechia |
| Ventolin Nebules | Latin | Australia |
| BULMOL | Latin | Morocco |
| INALER | Latin | Morocco |
| Salbutamol Cipla | Latin | Australia |
| Airomir Autohaler | Latin | Australia, South Africa |
| Asthavent Ecohaler | Latin | South Africa |
| Asthavent Syrup | Latin | South Africa |
| BUTOVENT | Latin | Morocco |
| DILATOR ECOSPRAY | Latin | Morocco |
| MAGISTRAL | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.